This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
La diversificación de los modelos de negocio: cómo lograr que múltiples modelos funcionen en su empresa
Sohl, Timo; Vroom, Govert; McCann, Brian T.Article HDBR-10Innovation and ChangePara ser más competitivas y poder adaptarse a los cambios del mercado, cada vez son más las empresas que optan por operar con varios modelos de negocio a la vez. En la mayoría de casos, se sigue empleando el modelo original y se adopta un modelo nuevo, disruptivo, de forma paralela. Para minimizar los obstáculos que presenta este proceso, es importante saber que adoptar modelos que no tienen relación entre sí es más complicado que adoptar modelos...Starting at €8.20
-
Spotify: Face the Music (Update 2016) - Teaching Note: Facing Increased Competition
Sastre Boquet, Isaac; Vroom, GovertTeaching Note SMT-112-EStrategyThe case describes the business model of the music streaming company Spotify, setting it against the backdrop of a music industry that had faced steep revenue declines since the advent of digital formats in the late 1990s and the rise of illegal file sharing. The case also presents the competition Spotify faces from the likes of Pandora, Google and Apple and asks whether Spotify has a viable long-term business model despite its explosive user and...Starting at €0.00
-
Spotify: Face the Music (Update 2018) - Teaching Note: Seeking Profitability
Sastre Boquet, Isaac; Vroom, GovertTeaching Note SMT-119-EInformation Technologies, Innovation and Change, StrategySpotify reached $3 billion in revenues in 2016, amid a booming music-streaming market that now made up 51% of the U.S. music industry's total revenues. Finally the industry had embraced digitization and was now seeing two-digit growth for the first time in decades. However, that growth had an Achilles' heel. Spotify itself was staring at an operating loss of $350 million, having never been able to post a profit in all its years of existence. Now,...Starting at €0.00
-
Axel Springer in 2016: From Transformation to Acceleration
Burgelman, R; Siegel, R; Kissick, RCase SGSB-E610-EEntrepreneurshipAs of 2016, Mathias Döpfner, chief executive officer (CEO) of Axel Springer SE, had successfully transitioned the German publishing house through a major digital transformation in the world of journalism. Given the massive disruption that had occurred over the previous two decades with how people consumed news, this was no small feat. During this time, many newspapers, magazines, and journals failed to keep up with the rapidly changing industry...Starting at €8.20
-
Charles Schwab Corp. in 2017
Siegel, R; Makinen, JCase SGSB-SM282-EStrategyBy almost any measure, Charles Schwab Corp. appeared to be killing it in 2017. The wealth management, banking, custody and brokerage firm’s stock was trading near its all-time high. It was posting unprecedented levels of new client accounts, net new client assets, revenues and profits and had a record $3.12 trillion in client assets under management. Schwab was taking customers and assets from old-line wire houses like Morgan Stanley, while fendi...Starting at €8.20
-
Minted in 2017: Designing a Profitable Brand
Siegel, R; Kuyel, SCase SGSB-SM275-EStrategyMariam Naficy (Minted CEO) and Melissa Kim (Minted COO) have grown the company to become a leader in the online printed cards, independent design and art market segments. As the business has continued to scale they wrestle with simultaneously growing their existing business while also looking at expanding into new markets, all the while keeping their existing customer base engaged. The case highlights the difficult decisions management faces in d...Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
Waste Management's Organic Growth Group
Burgelman, R; Siegel, R; Uribe, TCase SGSB-SM210-EStrategyIt was 2005 and David Steiner, CEO of Waste Management (WM), had just received a report from an internal advisory panel created some months before to assess the future of the waste management industry and propose how the company’s strategy should be adapted. The core of this report was the recommendation to create a special unit within the company, chartered with the central purpose of identifying ways to extract value from waste through new and ...Starting at €8.20
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209A-EStrategyFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Starting at €8.20